Angelos M. Stergiou has sold SLS and made no open-market buys since Jan 2019
President and CEO at SELLAS Life Sciences Group, Inc.
SEC CIK 0001724253 · Filings on SEC.gov ↗
$0Bought
$29KSold
NoneLast buy
Every filing
1 filing since Jan 2019, newest first
Filings come from SEC EDGAR. Not investment advice.